HIV infection among injection drug users (IDUs) in San Francisco is strongly associated with sexual behavior, with men who have sex with men (MSM) and women who trade sex for money much more likely to become infected than other IDUs, according to a study by UCSF researchers.

African American and Hispanic senior citizens who lack prescription drug benefits are three times more likely than white seniors to cut back on taking their medications, according to a study from researchers at San Francisco Veterans Affairs Medical Center.

The first patent for a method of delivering normal genes in a pill to induce the production of insulin in people with diabetes was issued May 1 to the University of California, San Francisco by the United States Patent and Trademark Office.

Men who have sex with men (MSM) who are victims of childhood sexual abuse are more likely to engage in risky sexual behavior than other MSMs, say researchers from UCSF's Center for AIDS Prevention (CAPS).

Researchers led by UCSF scientists are reporting that a highly effective clot busting drug for stroke is significantly underutilized in all patient populations at U.S. academic medical centers, and is strikingly underutilized in African Americans.

Simplifying women's access to hormonal contraceptives such as the pill would improve women's health, according to a UCSF study that appears in today's issue of the Journal of the American Medical Association (JAMA).

The highways and byways through which the brain exchanges messages require maintenance much as any municipal road. What would happen if such debris were left to accumulate? Alzheimer's disease would result.

The costs of caring for California community residents with Alzheimer's disease will increase 83 percent by 2020 and an additional 59 percent by 2040, according to UCSF researchers from the Institute for Health and Aging.

University of California, San Francisco researchers are reporting direct evidence that sleep in early life may play a crucial role in brain development.

A new study led by a University of California, San Francisco researcher shows that although raloxifene does not affect the cognitive performance of most women, it may help prevent decline among women older than 70 and women whose cognitive performance is declining regardless of age.